Stress regulation in multiple sclerosis - current issues and concepts

被引:25
作者
Heesen, C. [1 ]
Mohr, D. C.
Huitinga, I.
Bergh, F. Then
Gaab, J.
Otte, C.
Gold, S. M.
机构
[1] Univ Hamburg, Ctr Med, Dept Neurol, Hamburg, Germany
[2] Univ Calif San Francisco, VAMC, Dept Psychiat, San Francisco, CA USA
[3] Univ Calif San Francisco, VAMC, Dept Neurol, San Francisco, CA USA
[4] AZ Amsterdam, VUMC, Netherlands Inst Neurosci & MS Ctr, Amsterdam, Netherlands
[5] Univ Zurich, Klin Psychol & Psychotherapie, Psychol Inst, Zurich, Switzerland
[6] Univ Hamburg, Med Ctr, Dept Psychiat, Hamburg, Germany
[7] Univ Calif Los Angeles, Sch Med, Dept Neurol, Multiple Sclerosis Program, Los Angeles, CA USA
[8] Univ Calif Los Angeles, Sch Med, Cousins Ctr Psychoneuroimmunol, Neruopsychiat Inst, Los Angeles, CA USA
关键词
adrenoreceptor; autonomous nervous system; experimental stress; glucocorticoids; hypothalamo-pituitary-adrenal axis; stressful life events;
D O I
10.1177/1352458506070772
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since its first description by Charcot, psychological stress has been considered a triggering factor for exacerbations in multiple sclerosis, but until recently the clinical evidence for a causal relation was weak. Over the past years, a growing number of studies have started to elucidate this association and highlight potential mechanisms, including brain-immune communication. On 5 June 2005, a panel of international researchers discussed the current evidence. This article summarizes the observational, animal experimental, as well as human experimental findings on stress regulation in MS, as well as studies on the functioning of the major stress response systems, ie, the hypothalamo-pituitary-adrenal (HPA) axis and the autonomous nervous system (ANS) in MS. Consensus statements from the group to these aspects are given. Research objectives and strategies are delineated, as well as clinical implications.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 33 条
[1]   Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls [J].
Ackerman, KD ;
Martino, M ;
Heyman, R ;
Moyna, NM ;
Rabin, BS .
PSYCHOSOMATIC MEDICINE, 1998, 60 (04) :484-491
[2]   Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis:: A randomized, double blind trial [J].
Bergh, FT ;
Kümpfel, T ;
Grasser, A ;
Rupprecht, R ;
Holsboer, F ;
Trenkwalder, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1610-1615
[3]   Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS [J].
Bergh, FT ;
Kümpfel, T ;
Trenkwalder, C ;
Rupprecht, R ;
Holsboer, F .
NEUROLOGY, 1999, 53 (04) :772-777
[4]   A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables [J].
Brown, RF ;
Tennant, CC ;
Dunn, SM ;
Pollard, JD .
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (04) :477-484
[5]   Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice [J].
Chandler, N ;
Jacobson, S ;
Esposito, P ;
Connolly, R ;
Theoharides, TC .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (06) :757-763
[6]   Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats [J].
Correa, SG ;
Rodriguez-Galan, MC ;
Rivero, VE ;
Riera, CM .
BRAIN BEHAVIOR AND IMMUNITY, 1998, 12 (02) :134-148
[7]   Astrocytic β2-adrenergic receptors and multiple sclerosis [J].
De Keyser, J ;
Zeinstra, E ;
Wilczak, N .
NEUROBIOLOGY OF DISEASE, 2004, 15 (02) :331-339
[8]   Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production [J].
DeRijk, RH ;
Eskandari, F ;
Sternberg, EM .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 151 (1-2) :180-188
[9]   Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis [J].
Filippi, M ;
Rocca, MA ;
Martino, G ;
Horsfield, MA ;
Comi, G .
ANNALS OF NEUROLOGY, 1998, 43 (06) :809-814
[10]   Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability [J].
Flachenecker, P ;
Reiners, K ;
Krauser, M ;
Wolf, A ;
Toyka, KV .
MULTIPLE SCLEROSIS, 2001, 7 (05) :327-334